Activity
SD BIOSENSOR is a global company specializing in the development and manufacturing of in vitro diagnostic (IVD) products, contributing to the rapid and accurate detection of diseases through innovative technologies and diagnostic platforms.
History
SD BIOSENSOR was founded in 2010 and has since experienced significant growth, expanding its international presence with subsidiaries in several countries. The company has developed and launched multiple diagnostic products, obtaining certifications and regulatory approvals from organizations such as the WHO and national authorities. It has made strategic acquisitions and established factories and automation centers to strengthen its production and technological capacity.
Product types
The company offers a wide range of in vitro diagnostic products, including rapid diagnostic systems (STANDARD Q), fluorescent immunoassays (STANDARD F), enzyme-linked immunosorbent assays (STANDARD E), point-of-care molecular systems (STANDARD M), infectious disease diagnostics, and blood glucose monitoring (BGMS). Highlights include diagnostic kits for COVID-19, tuberculosis, cardiovascular, hormonal, and tumor diseases, as well as automated analyzers and cartridges for molecular testing.
Mission
SD BIOSENSOR's mission is to be a leading global in vitro diagnostics company, providing rapid and accurate diagnostic reagents to improve human health through technological innovation. Its vision is to contribute to global health with a comprehensive offering of diagnostic platforms, from screening to confirmatory testing, and to promote sustainability and responsible management through innovation and commitment to society and the environment.